Litigation Details for Custopharm, Inc. v. Fresenius Kabi USA, LLC (W.D. Tex. 2021)
✉ Email this page to a colleague
Custopharm, Inc. v. Fresenius Kabi USA, LLC (W.D. Tex. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-02-16 |
| Court | District Court, W.D. Texas | Date Terminated | 2021-03-26 |
| Cause | 35:271 Patent Infringement | Assigned To | Alan D. Albright |
| Jury Demand | None | Referred To | |
| Patents | 10,398,669; 9,006,289; 9,168,238; 9,168,239; 9,782,376 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Custopharm, Inc. v. Fresenius Kabi USA, LLC
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Custopharm, Inc. v. Fresenius Kabi USA, LLC (W.D. Tex. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-02-15 | 1 | Complaint | non-infringement of U.S. Patent Nos. 9,782,376 (“the ’376 patent”) (attached as Exhibit A) and 10,398,669 (“the ’669…Judgment of non-infringement of U.S. Patent Nos. 9,782,376 and 10,398,669 against Fresenius Kabi USA, LLC … 30 17-376 Patent, # 9 Exhibit H-Notice of Allowance 376 Patent, # 10 Exhibit I-669 Patent Application…Civil Cover Sheet, # 2 Exhibit A-Patent US9782376, # 3 Exhibit B-Patent US10398669, # 4 Exhibit C-043 Order… Exhibit E-376 Patent Application, # 7 Exhibit F-Office Action Dated 2 27 17-376 Patent, # 8 Exhibit G-Office | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
